Legal & General Group’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
32,048
-4,318
-12% -$142K ﹤0.01% 2130
2025
Q4
$1.15M Sell
36,366
-1,417
-4% -$42.6K ﹤0.01% 2178
2025
Q3
$888K Buy
37,783
+6,706
+22% +$115K ﹤0.01% 2277
2025
Q2
$353K Sell
31,077
-4,270
-12% -$40.5K ﹤0.01% 2532
2025
Q1
$235K Hold
35,347
﹤0.01% 2584
2024
Q4
$390K Buy
35,347
+1,540
+5% +$18.9K ﹤0.01% 2546
2024
Q3
$415K Buy
33,807
+1,017
+3% +$14.4K ﹤0.01% 2523
2024
Q2
$443K Buy
32,790
+30,512
+1,339% +$412K ﹤0.01% 2457
2024
Q1
$30.8K Sell
2,278
-851
-27% -$5.16K ﹤0.01% 2849
2023
Q4
$16.5K Sell
3,129
-7,805
-71% -$33.4K ﹤0.01% 3108
2023
Q3
$43.1K Sell
10,934
-4,258
-28% -$28K ﹤0.01% 2885
2023
Q2
$161K Buy
15,192
+11,971
+372% +$127K ﹤0.01% 2783
2023
Q1
$26.8K Sell
3,221
-3,077
-49% -$27.8K ﹤0.01% 2989
2022
Q4
$58.1K Hold
6,298
﹤0.01% 2925
2022
Q3
$81K Buy
6,298
+1,056
+20% +$16.8K ﹤0.01% 2877
2022
Q2
$69K Sell
5,242
-39
-0.7% -$592 ﹤0.01% 2941
2022
Q1
$111K Hold
5,281
﹤0.01% 2840
2021
Q4
$127K Buy
5,281
+29
+0.6% +$692 ﹤0.01% 2857
2021
Q3
$134K Buy
5,252
+2,532
+93% +$70.6K ﹤0.01% 2789
2021
Q2
$92K Buy
2,720
+715
+36% +$25.3K ﹤0.01% 2770
2021
Q1
$78K Buy
2,005
+220
+12% +$12.5K ﹤0.01% 2687
2020
Q4
$110K Sell
1,785
-555
-24% -$25.4K ﹤0.01% 2563
2020
Q3
$79K Buy
2,340
+281
+14% +$8.02K ﹤0.01% 2552
2020
Q2
$49K Sell
2,059
-559
-21% -$13.3K ﹤0.01% 2735
2020
Q1
$60K Buy
2,618
+816
+45% +$20.2K ﹤0.01% 2547
2019
Q4
$51K Buy
1,802
+312
+21% +$7.85K ﹤0.01% 2805
2019
Q3
$32K Buy
+1,490
New +$41.5K ﹤0.01% 2940

Other funds holding STOK